Menu
Menu
Menu
Menu
EffRx Pharmaceuticals is a Swiss-based commercial-stage pharmaceutical company focused on the late-stage development and commercialization of niche endocrine, metabolic and musculoskeletal disorders’ medications.
We are a lean, customer-centric and people-cantered organization with key competences across the pharmaceutical value chain. Our people are guided by a common purpose, namely to improve patients’ health and improving patients’ outcomes and their quality of life. We work cross-functionally, exhibit swift decision cycles thus offering accelerated responses and time to market to our customers.
Since 2023 EffRx is controlled by Abiogen Pharma S.p.A., an Italian leading company in the field of osteoarticular and bone metabolism diseases.
We aim to be the dedicated and preferred Swiss and European accelerator for late clinical development, approval and valorization of niche medicines that address high unmet medical needs.
We are committed to improve patient’s lives with medicines addressing high unmet medical needs.
